Anne Knupp Crossway ’78 Will Give This Year's Keynote Speech
A business and biosciences consultant, Anne Knupp Crossway ’78 will deliver the keynote address on “Nature Versus Nurture” at 11:30 a.m. in Old Main Brown Auditorium.
With more than 25 years experience in the life sciences, Crossway has offered her consulting services to clients that include bioscience companies in early stages of development and non-profit science and technology organizations. She currently bases her business out of Leander, Texas, where her husband, Thomas, is an administrator of the Leander Independent School District.
Crossway was previously president and CEO of CIStem Molecular, a genomics company with a systems biology gene expression technology. Before that, she was CEO of Cosmederm Technologies, a biotech-based dermatological products company. Crossway was brought in by the major investors to lead its successful turnaround.
Her earlier career includes venture capital experience as well as progressively responsible technical and management positions in companies in the early stage of development within the biotechnology, consumer products and over-the-counter (OTC) drug/device industries. While serving as a managing scientist at the first agricultural biotechnology company, Calgene, Inc., she authored scientific publications, book chapters and patents in the biotechnology field.
In addition to consulting for numerous bioscience companies, Crossway has been a management fellow at UCSD CONNECT, a technology and entrepreneurship organization at University of California at San Diego (UCSD). She has also has been a senior advisor to Building Engineering and Science Talent (BEST) and to Springboard Enterprises, a women’s venture capital group. She is a past president and director of UCSD Athena, a business organization for senior executives in high-tech and life-science companies in San Diego County.
A native of DeRuyter, N.Y., Crossway graduated summa cum laude with a Bachelor of Science in Biology from SUNY Cortland. She earned an MBA from the Stanford University Graduate School of Business and a doctorate in genetics from the University of California at Davis.